LEAP THERAPEUTICS CEO Douglas Onsi's 2020 pay jumps 185% to $2.3M
LEAP THERAPEUTICS reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
LEAP THERAPEUTICS reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, four executives at LEAP THERAPEUTICS received on average a compensation package of $1.2M, a 49% increase compared to previous year.
Average pay of disclosed executives at LEAP THERAPEUTICS
Douglas E. Onsi, Chief Executive Officer, received $2.3M in total, which increased by 185% compared to 2019. 40% of Onsi's compensation, or $938K, was in stock awards. Onsi also received $308K in non-equity incentive plan, $528K in option awards, $513K in salary, as well as $45K in other compensation.
Cynthia Sirard, Chief Medical Officer, received a compensation package of $1M. 41% of the compensation package, or $427K, was in option awards.
Augustine Lawlor, Chief Operating Officer, earned $751K in 2020, a 8% decrease compared to previous year.
Christopher K. Mirabelli, Chief Executive Officer, received $744K in 2020, which decreases by 8% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2021.